SafroPam
Natural health product licensed in Canada
- Licence holder
- Pamblu Pharma Inc.
- NPN or DIN-HM
- 80082465
- Status
- Active licence
- Licence date
- 18 January 2018
- Revision date
- Not provided
- Form
- Capsule, molle
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Curcuma longa Source : Rhizome | 200 mg |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
Dosage not provided.
Uses authorised in Canada
Use not provided.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80082465
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.